Navigation Links
Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single-Stranded RNAi Technology
Date:9/10/2009

CAMBRIDGE, Mass. and CARLSBAD, Calif., Sept. 10 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs. Last year, Isis was awarded patents covering the compositions and methods of treating patients with a double-stranded or a single-stranded RNA-containing compounds, including double-stranded small interfering RNA (siRNA), which further strengthened Isis' broadly applicable intellectual property estate covering RNA-based drug discovery and development.

Isis' Crooke patent estate is a family of patents stemming from the innovative research of Stanley Crooke, M.D., Ph.D., and others at Isis to identify and design RNA molecules that utilize numerous different antisense mechanisms. Isis continues this research effort by utilizing its RNA expertise with its broad oligonucleotide medicinal chemistry endeavors to design drugs that are optimal to exploit each different mechanism and have attractive pharmaceutical properties. The Crooke patents are part of Isis' patent estate, which includes more than 1,600 issued patents worldwide and broadly covers the design and use of RNA-containing drugs. The Crooke patent estate is owned by Isis and licensed co-exclusively to Alnylam for RNAi drugs, and exclusively licensed to Regulus T
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.; Alnylam Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Childrens Hospital receives federal contract to study antibiotic use in children with UTIs
2. Emdeon Receives EHNAC Healthcare Network Re-accreditation
3. ARUP Laboratories Scientist Tanya Sandrock Receives NIH Grant to Search for Additional HIV Therapies
4. Kidz-Med Inc. Receives Follow-Up Purchase Order Leading to Highest Revenue Week at Beginning of Cold and Flu Season
5. Kidz-Med Inc. Receives Large Purchase Order Leading to Substantial Sales Increase at Beginning of Cough and Cold Season
6. IMRIS receives FDA clearance for IMRISNV and IMRIScardio
7. Conseco Receives Approval to Complete Reinsurance Transaction with Wilton Re
8. Milliman Consultant Receives Prestigious CDC Scientific Award
9. Restorative Therapies, Inc., Receives FDA Clearance for RT300 Enhancements
10. The Sebastian Ferrero Foundation Receives a $5 Million Gift From Google Executive for Childrens Hospital
11. Fox Chase Cancer Center receives $8 million NIH grant to expand laboratory animal research facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Claflin Medical Equipment , a ... acquisition of RSI Equipment, Inc ., a ... 2015. , With CME’s recent merger of Hospital ... three premier organizations which specialize in the procurement and ... By combining forces, they now cover the entire country ...
(Date:6/2/2015)... ZOOM+, the Portland-based health innovator of on-demand ... today the opening of its on-demand ZOOM+Smile studio. ZOOM+Smile ... complete dental exam, cleaning and whitening in 57 minutes, ... ZOOM+ services, ZOOM+Smile can be scheduled by mobile phone ... be as inviting as your favorite coffee shop?” said ...
(Date:6/2/2015)... 02, 2015 Acara Partners has seen a ... responsive to mobile devices, as is now required by recent ... clients, as well as several new clients in the medical ... website for them to meet Google’s new requirements,” commented Fran ... with our clients in education, non-profits, and the business world.” ...
(Date:6/2/2015)... 02, 2015 Olive Fertility ... of Surrey’s first fertility clinic. Surrey is ... diverse, young community, with one of Canada’s ... , Until now patients from Surrey and ... come into Vancouver or Burnaby for fertility ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ANT ... technology, highlights North Pole Engineering’s (NPE) announcement of ... Wireless technologies: WASP-N, WASP-PoE-2 and WASP-PoE-3. WASP is ... and Bluetooth Smart® bridge solution that allows data ... over WiFi or Ethernet networks. , ...
Breaking Medicine News(10 mins):Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3
... By Dennis Thompson HealthDay Reporter , FRIDAY, ... as good for the body -- nourishing, boosting disease-fighting ability ... adopt it, especially when the bodies it helps are babies,. ... least when it comes to breast-feeding. A large number ...
... 11, 2011 A clinical trial testing the efficacy ... through plaque deposits) prior to implantation of a drug-eluting ... standard balloon angioplasty and decreased the efficacy of the ... vessel. Results of the ROTAXUS (A Prospective, ...
... 11, 2011 A clinical trial of patients ... to conventional balloon angioplasty in the superficial femoral ... (ISR). Results from the COBRA clinical trial were ... Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular ...
... Nov. 11 (HealthDay News) -- A healthy lifestyle may help ... life, a new study suggests. Due to repeated head ... sports and non-athletes to suffer cognitive problems as they age. ... former college football players and found that those who ate ...
... 2011 A clinical trial has established the ... polymer compared to a drug-eluting stent with a ... were presented today at the 23rd annual Transcatheter ... Cardiovascular Research Foundation. Durable polymer coatings on ...
... Researchers have found that polymer-free amphilimus-eluting stents ... significantly lower in-stent late loss at six months ... Results of the NEXT trial were presented ... (TCT) scientific symposium, sponsored by the Cardiovascular Research ...
Cached Medicine News:Health News:Exclusive Breast-Feeding Not the Norm in U.S. 2Health News:Exclusive Breast-Feeding Not the Norm in U.S. 3Health News:Exclusive Breast-Feeding Not the Norm in U.S. 4Health News:Results of the ROTAXUS trial reported at TCT 2011 2Health News:Results of the COBRA trial reported at TCT 2011 2Health News:Former Football Players' Brains May Benefit From Healthy Lifestyle 2Health News:Results of the EVOLVE trial reported at TCT 2011 2Health News:Results of the NEXT clinical trial Reported at TCT 2011 2
(Date:6/2/2015)... June 2, 2015 The Canadian Society for Vascular ... tests, treatments or procedures that are commonly ordered ... part of Choosing Wisely Canada.  The list identifies ... conversations between patients and physicians about what care ... for Vascular Surgery,s list identified the following five ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5tzcx6/specialty_enzymes ) has ... Global Strategic Business Report" report to their offering. ... following End-Use Applications: Pharmaceutical & Diagnostics, Research/ Biotechnology, and ... US, Canada , Japan ... Asia-Pacific , Latin America , ...
(Date:6/2/2015)... , June 2, 2015 ... (HIT) consulting firm, today announced the celebration of ... served throughout the U.S., since its inception in ... a skillful workforce in the healthcare technology industry ... with a company-wide dedication to facilitating clients, organizational ...
Breaking Medicine Technology:As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 2As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 3As part of the Choosing Wisely Canada campaign the Canadian Society for Vascular Surgery releases list of commonly used tests and treatments to question 4Specialty Enzymes - Global Strategic Business Report 2015: Indispensable to the Pharmaceutical Industry 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 2Stoltenberg Consulting celebrates 20 years of healthcare IT consulting service 3
... to the American Diabetes Association, total costs of diagnosed ... at $174 billion.  Millions of Americans have been diagnosed ... that they are at risk or in fact living ... pills to manage their diabetes and these medications can ...
... Mass., Nov. 1, 2010 Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... dedicated to serving the healthcare needs of women, ... American Society of Breast Surgeons (ASBS) MammoSite® Breast ...
Cached Medicine Technology:Stater Bros. Super Rx Pharmacy Offers FREE Diabetic Medications 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 3
Inquire...
Inquire...
Single-action scissors offer fine-pointed, sharp dissecting jaws to facilitate a partial cut in the cystic duct in preparation for a cholangiogram. They are tapered at the tip for greater visualizati...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: